Skip to main content

St. Jude in top five of elite ranking of hospitals treating children with cancer

Memphis, Tennessee, June 21, 2023

Patient Care Center, Pavilion, Danny Thomas Research Center, Kay Research and Care Center, Pyramid, Downtown Memphis, Best Hospitals for Children with Cancer, U.S. News

St. Jude Children’s Research Hospital is ranked among the top five children’s hospitals for cancer by U.S. News & World Report. 

St. Jude Children’s Research Hospital is ranked again among the top five pediatric cancer hospitals on U.S. News & World Report’s 17th Annual “Best Children’s Hospitals” list released today. The publication evaluates approximately 100 hospitals with pediatric oncology programs annually and ranks the top 50 programs.

The U.S. News Best Children’s Hospitals rankings rely on clinical data and an annual survey of pediatric specialists. The study factors in clinical resources such as bone marrow transplantation services, brain tumors and sarcomas programs and FACT accreditation (for cellular therapy). The survey also evaluates compliance with best practices and patient outcomes, such as mortality and infection rates.

USNWR badge

“Being named a best children’s hospital for cancer year after year is a testament to the work our employees do every day toward our mission of finding cures and saving children,” said James R. Downing, M.D., St. Jude president and chief executive officer. “We are committed to accelerating progress in understanding and treating childhood cancer and other pediatric catastrophic diseases. We welcome the best and brightest in the field to join us in our goal of improving care not only throughout the United States but on a global scale.”

St. Jude is the only National Cancer Institute-designated Comprehensive Care Center devoted solely to children. The Cancer Center supports five major interdisciplinary research programs organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer while minimizing long-term side effects.

The institution has top survival rates for some of the most common and aggressive childhood cancers, including acute lymphoblastic leukemia. It has nearly doubled the survival rates for medulloblastoma, the most common malignant brain tumor in children. St. Jude has committed to developing new therapeutic approaches aimed at curing pediatric cancers considered to be incurable.

“This is a remarkable achievement, made possible by everyone across the clinical enterprise who demonstrate tireless dedication to improving our patients’ lives,” said Ellis Neufeld, M.D., Ph.D., St. Jude clinical director, physician-in-chief and executive vice president. “We are always seeking ways to improve treatment for our patients, and this recognition, year after year, confirms that commitment.”

St. Jude has maintained designated Magnet status by the American Nurses Credentialing Center. Magnet status is the highest honor granted to nursing services; only nine percent of all U.S. hospitals have achieved this recognition. The program recognizes healthcare organizations that demonstrate excellence in nursing philosophy and practice, adherence to national standards for improving patient care, leadership and sensitivity to cultural and ethnic diversity.


St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.